Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1956 2
1957 2
1958 2
1959 5
1962 1
1963 3
1964 5
1965 7
1966 4
1967 6
1968 3
1969 8
1970 2
1971 6
1972 10
1973 22
1974 12
1975 12
1976 11
1977 5
1978 7
1979 6
1980 4
1981 13
1982 10
1983 7
1984 10
1985 8
1986 17
1987 5
1988 14
1989 9
1990 8
1991 8
1992 10
1993 3
1994 10
1995 7
1996 2
1997 4
1998 5
1999 4
2000 6
2001 5
2002 5
2003 9
2004 10
2005 7
2006 11
2007 12
2008 6
2009 6
2010 6
2011 7
2012 11
2013 8
2014 13
2015 12
2016 13
2017 8
2018 13
2019 10
2020 12
2021 11
2022 11
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

507 results

Results by year

Filters applied: . Clear all
Page 1
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.
Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, Huck J, Shi J, Gavin J, Brownell J, Yang Y, Stringer B, Griffin R, Bruzzese F, Soucy T, Duffy J, Rabino C, Riceberg J, Hoar K, Lublinsky A, Menon S, Sintchak M, Bump N, Pulukuri SM, Langston S, Tirrell S, Kuranda M, Veiby P, Newcomb J, Li P, Wu JT, Powe J, Dick LR, Greenspan P, Galvin K, Manfredi M, Claiborne C, Amidon BS, Bence NF. Hyer ML, et al. Among authors: gavin j. Nat Med. 2018 Feb;24(2):186-193. doi: 10.1038/nm.4474. Epub 2018 Jan 15. Nat Med. 2018. PMID: 29334375
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models.
Lightcap ES, Yu P, Grossman S, Song K, Khattar M, Xega K, He X, Gavin JM, Imaichi H, Garnsey JJ, Koenig E, Zhang H, Lu Z, Shah P, Fu Y, Milhollen MA, Hatton BA, Riceberg J, Shinde V, Li C, Minissale J, Yang X, England D, Klinghoffer RA, Langston S, Galvin K, Shapiro G, Pulukuri SM, Fuchs SY, Huszar D. Lightcap ES, et al. Among authors: gavin jm. Sci Transl Med. 2021 Sep 15;13(611):eaba7791. doi: 10.1126/scitranslmed.aba7791. Epub 2021 Sep 15. Sci Transl Med. 2021. PMID: 34524860 Free PMC article.
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.
Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, Brownell JE, Burke KE, Cardin DP, Critchley S, Cullis CA, Doucette A, Garnsey JJ, Gaulin JL, Gershman RE, Lublinsky AR, McDonald A, Mizutani H, Narayanan U, Olhava EJ, Peluso S, Rezaei M, Sintchak MD, Talreja T, Thomas MP, Traore T, Vyskocil S, Weatherhead GS, Yu J, Zhang J, Dick LR, Claiborne CF, Rolfe M, Bolen JB, Langston SP. Soucy TA, et al. Among authors: gavin jm. Nature. 2009 Apr 9;458(7239):732-6. doi: 10.1038/nature07884. Nature. 2009. PMID: 19360080
Microvascular involvement in cardiac pathology.
Gavin JB, Maxwell L, Edgar SG. Gavin JB, et al. J Mol Cell Cardiol. 1998 Dec;30(12):2531-40. doi: 10.1006/jmcc.1998.0824. J Mol Cell Cardiol. 1998. PMID: 9990524 Review.
Coronary heart disease in African Americans.
Clark LT, Ferdinand KC, Flack JM, Gavin JR 3rd, Hall WD, Kumanyika SK, Reed JW, Saunders E, Valantine HA, Watson K, Wenger NK, Wright JT. Clark LT, et al. Among authors: gavin jr 3rd. Heart Dis. 2001 Mar-Apr;3(2):97-108. doi: 10.1097/00132580-200103000-00007. Heart Dis. 2001. PMID: 11975778 Review.
Biosynthetic studies of the DSP toxin skeleton.
Daranas AH, Fernández JJ, Norte M, Gavín JA, Suárez-Gómez B, Souto ML. Daranas AH, et al. Among authors: gavin ja. Chem Rec. 2004;4(1):1-9. doi: 10.1002/tcr.10072. Chem Rec. 2004. PMID: 15057864 Review.
507 results